Cargando…

Humoral response to mRNA‐based COVID‐19 vaccine in patients with de novo and pre‐existing immune thrombocytopenia with exacerbation of thrombocytopenia after vaccination

Detalles Bibliográficos
Autores principales: Mori, Akio, Onozawa, Masahiro, Kobayashi, Mirei, Tsukamoto, Shihori, Ishio, Takashi, Yokoyama, Emi, Izumiyama, Koh, Saito, Makoto, Muraki, Haruna, Morioka, Masanobu, Teshima, Takanori, Kondo, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538325/
https://www.ncbi.nlm.nih.gov/pubmed/36096497
http://dx.doi.org/10.1111/bjh.18447
_version_ 1784803337816768512
author Mori, Akio
Onozawa, Masahiro
Kobayashi, Mirei
Tsukamoto, Shihori
Ishio, Takashi
Yokoyama, Emi
Izumiyama, Koh
Saito, Makoto
Muraki, Haruna
Morioka, Masanobu
Teshima, Takanori
Kondo, Takeshi
author_facet Mori, Akio
Onozawa, Masahiro
Kobayashi, Mirei
Tsukamoto, Shihori
Ishio, Takashi
Yokoyama, Emi
Izumiyama, Koh
Saito, Makoto
Muraki, Haruna
Morioka, Masanobu
Teshima, Takanori
Kondo, Takeshi
author_sort Mori, Akio
collection PubMed
description
format Online
Article
Text
id pubmed-9538325
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95383252022-10-11 Humoral response to mRNA‐based COVID‐19 vaccine in patients with de novo and pre‐existing immune thrombocytopenia with exacerbation of thrombocytopenia after vaccination Mori, Akio Onozawa, Masahiro Kobayashi, Mirei Tsukamoto, Shihori Ishio, Takashi Yokoyama, Emi Izumiyama, Koh Saito, Makoto Muraki, Haruna Morioka, Masanobu Teshima, Takanori Kondo, Takeshi Br J Haematol Letters to the Editor John Wiley and Sons Inc. 2022-09-12 /pmc/articles/PMC9538325/ /pubmed/36096497 http://dx.doi.org/10.1111/bjh.18447 Text en © 2022 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Mori, Akio
Onozawa, Masahiro
Kobayashi, Mirei
Tsukamoto, Shihori
Ishio, Takashi
Yokoyama, Emi
Izumiyama, Koh
Saito, Makoto
Muraki, Haruna
Morioka, Masanobu
Teshima, Takanori
Kondo, Takeshi
Humoral response to mRNA‐based COVID‐19 vaccine in patients with de novo and pre‐existing immune thrombocytopenia with exacerbation of thrombocytopenia after vaccination
title Humoral response to mRNA‐based COVID‐19 vaccine in patients with de novo and pre‐existing immune thrombocytopenia with exacerbation of thrombocytopenia after vaccination
title_full Humoral response to mRNA‐based COVID‐19 vaccine in patients with de novo and pre‐existing immune thrombocytopenia with exacerbation of thrombocytopenia after vaccination
title_fullStr Humoral response to mRNA‐based COVID‐19 vaccine in patients with de novo and pre‐existing immune thrombocytopenia with exacerbation of thrombocytopenia after vaccination
title_full_unstemmed Humoral response to mRNA‐based COVID‐19 vaccine in patients with de novo and pre‐existing immune thrombocytopenia with exacerbation of thrombocytopenia after vaccination
title_short Humoral response to mRNA‐based COVID‐19 vaccine in patients with de novo and pre‐existing immune thrombocytopenia with exacerbation of thrombocytopenia after vaccination
title_sort humoral response to mrna‐based covid‐19 vaccine in patients with de novo and pre‐existing immune thrombocytopenia with exacerbation of thrombocytopenia after vaccination
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538325/
https://www.ncbi.nlm.nih.gov/pubmed/36096497
http://dx.doi.org/10.1111/bjh.18447
work_keys_str_mv AT moriakio humoralresponsetomrnabasedcovid19vaccineinpatientswithdenovoandpreexistingimmunethrombocytopeniawithexacerbationofthrombocytopeniaaftervaccination
AT onozawamasahiro humoralresponsetomrnabasedcovid19vaccineinpatientswithdenovoandpreexistingimmunethrombocytopeniawithexacerbationofthrombocytopeniaaftervaccination
AT kobayashimirei humoralresponsetomrnabasedcovid19vaccineinpatientswithdenovoandpreexistingimmunethrombocytopeniawithexacerbationofthrombocytopeniaaftervaccination
AT tsukamotoshihori humoralresponsetomrnabasedcovid19vaccineinpatientswithdenovoandpreexistingimmunethrombocytopeniawithexacerbationofthrombocytopeniaaftervaccination
AT ishiotakashi humoralresponsetomrnabasedcovid19vaccineinpatientswithdenovoandpreexistingimmunethrombocytopeniawithexacerbationofthrombocytopeniaaftervaccination
AT yokoyamaemi humoralresponsetomrnabasedcovid19vaccineinpatientswithdenovoandpreexistingimmunethrombocytopeniawithexacerbationofthrombocytopeniaaftervaccination
AT izumiyamakoh humoralresponsetomrnabasedcovid19vaccineinpatientswithdenovoandpreexistingimmunethrombocytopeniawithexacerbationofthrombocytopeniaaftervaccination
AT saitomakoto humoralresponsetomrnabasedcovid19vaccineinpatientswithdenovoandpreexistingimmunethrombocytopeniawithexacerbationofthrombocytopeniaaftervaccination
AT murakiharuna humoralresponsetomrnabasedcovid19vaccineinpatientswithdenovoandpreexistingimmunethrombocytopeniawithexacerbationofthrombocytopeniaaftervaccination
AT moriokamasanobu humoralresponsetomrnabasedcovid19vaccineinpatientswithdenovoandpreexistingimmunethrombocytopeniawithexacerbationofthrombocytopeniaaftervaccination
AT teshimatakanori humoralresponsetomrnabasedcovid19vaccineinpatientswithdenovoandpreexistingimmunethrombocytopeniawithexacerbationofthrombocytopeniaaftervaccination
AT kondotakeshi humoralresponsetomrnabasedcovid19vaccineinpatientswithdenovoandpreexistingimmunethrombocytopeniawithexacerbationofthrombocytopeniaaftervaccination